Jamie C. Barner, Ph.D., FAACP, FAPhA

Selected Recent Publications
*Denotes student(s)/trainee(s) at the time of the study.

CORE Research Area: Patient-Centered Outcomes Research

Ibiloye EA,* Odonkor GN,* Barner JC, Brown CM, Bamgbade BA, Aiyeolemi AA.* Factors influencing willingness to utilize the emergency department when experiencing sickle cell disease pain crises. Journal of the National Medical Association. 2025:117(5); 323–334. 

Odonkor GN,* Kang HA, Barner JC, Lawson KA, Fasipe T. Medical complications among children and adolescents with sickle cell disease in Texas Medicaid. Healthcare 2025, 13:18; 2288.

Bamgbade BA,* Barner JC, Brown CM, Ford KA, Burdine K, Lawson W. Impact of a psychoeducational intervention on willingness to seek help for depression among African American young adults. Transcultural Psychiatry. 2024;61(6):858-871. 

Mohan A,* Majd Z,* Johnson ML, Essien E, Barner JC, Serna O, Gallardo E, Fleming ML, Ordonez N, Holstad MM, Abughosh SM. A motivational interviewing intervention to improve adherence to ACEI/ARBs among nonadherent older adults with comorbid hypertension and diabetes. Drugs and Aging. 2023;40(4):377-390.

CORE Research Area: Healthcare Systems Research

Mueller H,* Barner JC, Brown CM, Stewart M. Exploring ambulatory care pharmacists’ beliefs and confidence in managing diabetes in perinatal women: A qualitative study guided by the theory of planned behavior. Forthcoming American Journal of Health Systems Pharmacists.

Mueller J,* Pennington E,* Carr, A,* Barner JC. Effectiveness of telehealth for disease management during the perinatal period: a scoping review. Telemedicine and e-Health. 2025; 31(8). 

Aiyeolemi A,* Barner JC, Brown CM, Fasipe T. Effect of an educational intervention on emergency department residents’ knowledge and perceptions of sickle cell disease: a pilot study. Journal of Sickle Cell Disease.2025:2(1), yoaf024.

Rose J,* Okoye B,* Aiyeolemi A,* Barner JC. Pharmacy students’ knowledge of sickle cell disease. Currents in Pharmacy Teaching and Learning. 2025;17(10), 102420. 

Unni EJ, Planas LG, Irwin A, Young H, Gannavarapu P, Nagel-Edwards K, Barner JC, Quiñones-Boex AC, Blakely ML, Clark MA, Devraj R, Suda KJ, Thomas T, Warholak T. Gender equity perceptions among pharmacy practice faculty in pharmacy academia. Journal of the American College of Clinical Pharmacy. 2025;8:271-280.

CORE Research Area: Health Economics and Outcomes Research

Pennington E,* Barner JC, Brown CM, Moczygemba LR, Patel DA. Predisposing, enabling, and need factors associated with postpartum depression treatment among women enrolled in Texas Medicaid. Maternal and Child Health. 2025 (July 17).

Pennington E,* Barner JC, Brown CM, Moczygemba LR, Patel DA, Varisco TJ. Antidepressant adherence using group-based trajectory modeling among postpartum women with Texas Medicaid. Journal of Managed Care and Specialty Pharmacy. 2025;31(2):167-78.

Pennington E,* Barner JC, Brown CM, Lawson KA. Pregnancy-related risk factors and receipt of postpartum care among Texas Medicaid pregnant enrollees: Opportunities for pharmacist services. Journal of the American Pharmacists Association. 2024;64(1):260-267. 

Kang HA, Wang B,* Barner JC, Ataga KI, Mignacca RC, Chang A, Zhang Y. Opioid prescribing and outcomes in patients with sickle cell disease post-2016 CDC guideline. JAMA Internal Medicine. 2024;184(5):510-518.

Kang HA, Barner JC, Rascati KL, Lawson KA, Mignacca RC. Impact of adherence to hydroxyurea on health outcomes among patients with sickle cell disease. American Journal of Hematology. 2023 Jan;98(1):90-101.

Graduate Courses

• PGS 181M Seminar in Market Access in the Life Science Industry (Topics: US and Ex-US Policies, Health Technology Assessment, Pricing, Evidence Generation Planning, Real World Evidence)
• PGS 196S Seminar in Pharmacy (Topics: Healthcare Databases, Patient Reported Outcomes, Patient Experience)
• PGS 390K Experimental Design and Research Methods in Health Care (Topics: Research Designs, Threats to Internal and External Validity, Power Analysis)
• PGS 390U Advanced Research Methods (Topics: Medication Adherence, Network Meta-Analysis, Logistic Regression, Patient Experience)

Pharm.D. Courses

• PHM 384L Pharmacy and the U.S. Health Care System (Topics: Utilization and Costs, Access to Care, Fraud and Abuse, Health Care Manpower, Hospitals, Long Term Care, Pharmaceutical Industry, Pharmacies)
• PHM 394F Principles of Pharmacoeconomics and Pharmacy Management (Topics: Human Resources Management, Health Information Technology, Risk Management)

Significant/Recent Activities

Invited Presentations

• Aiyeolemi A,* Barner JC. “Impact of an Intervention on Knowledge and Perceptions Among Sickle Cell Disease Providers, Texas Sickle Cell Action Plan Initiative, August 15, 2025.
• Aiyeolemi A,* Barner JC,  Fasipe T. “Sickle Cell Disease Management: Pediatric Considerations” for the Department of Pediatrics – Health Equity Rounds, UT Health San Antonio School of Medicine, June 20, 2025.
• Barner JC. “Barner Team Research in Sickle Cell Disease” for the Texas Department of State Health Services Sickle Cell Data Collection Multi-Disciplinary Team, June 13, 2024.
• Barner JC. “Patient Experience in the Emergency Department among Individuals Living with Sickle Cell Disease” for Admiral Rachel Levine, Assistant Secretary of Health, Health and Human Services, March 14, 2024.
• Barner JC. “Patient Experience and Factors Influencing Willingness to Utilize the Emergency Department among Individuals Living with Sickle Cell Disease” for the Texas Department of State Health Services Sickle Cell Disease Task Force, December 1, 2023.
• Barner JC, Kang H. “Sickle Cell Disease Health Outcomes Research” for the Texas Department of State Health Services Sickle Cell Disease Task Force, May 27, 2022.

National and International Service Activities

American Association of Colleges of Pharmacy

• 2021-2022, Past Chair, Social and Administrative Sciences Section
• 2021-2022, Chair, Nominations Committee
• 2021-2022, Chair, New Investigator Award Committee
• 2020-present, Member, Gender Equity Task Force; Joint Effort with APhA
• 2020-2021, Chair, Social and Administrative Sciences Section

American Pharmacists Association

• 2020-present Member, Gender Equity Task Force (Renamed: Leadership, Equity, & Advancement in Pharmacy); Joint Effort with AACP

University/College Service Activities

College of Pharmacy

• 2025- present Co-Chair, Industry Advisory Board
• 2024-present, Member, Opportunity and Engagement Committee
• 2022, 2023, Faculty Mentor, Leadership through Engagement for the Advancement of Diverse Educational Research (LEADER) program
• 2022-present, Member, Graduate Affairs and Curriculum Committee
• 2022-present, Concurrent Degrees, Pathways, and Programs Committee
• 2020-present, Advisory Board Member, Build Our Own Talent (BOOT) Program
• 2017-2023, Member, Diversity Equity, Accessibility, and Inclusion Committee
• 2015-present, Member, Translation Science PhD Committee on Graduate Studies
• 2009-2021, PharmD/PhD Oversight Committee
• 2000-present, Co-Advisor, Student National Pharmaceutical Association

SICKLE CELL DISEASE-RELATED RESEARCH

Provider/Trainee Knowledge/Education

Publications

• Aiyeolemi A,* Barner JC, Brown CM, Fasipe T. Effect of an educational intervention on emergency department residents’ knowledge and perceptions of sickle cell disease: a pilot study. Journal of Sickle Cell Disease.2025:2(1), yoaf024.
• Rose J,* Okoye B,* Aiyeolemi A,* Barner JC. Pharmacy students’ knowledge of sickle cell disease. Currents in Pharmacy Teaching and Learning. 2025;17(10), 102420.

Presentations 

• Rose J,* Okoye B,* Aiyeolemi A,* Barner JC. “Pharmacy students’ knowledge of sickle cell disease” at the The University of Texas College of Pharmacy Celebrating Research Day, Austin, TX, April 8, 2025.
• Aiyeolemi A,* Barner JC, Brown CM, Fasipe T. “Impact of an educational intervention on emergency department residents' knowledge and perceptions of sickle cell disease: a pilot study” at the American Society of Hematology Annual Meeting, San Diego, CA. December 7-10, 2024.
• Aiyeolemi A,* Barner JC. “Impact of an intervention on knowledge and perceptions among sickle cell disease providers, Texas Sickle Cell Action Plan Initiative, August 15, 2025.
• Aiyeolemi A,* Barner JC,  Fasipe T. “Sickle cell disease management: Pediatric considerations” for the Department of Pediatrics – Health Equity Rounds, UT Health San Antonio School of Medicine, June 20, 2025.

Patient Outcomes

Publications

• Ibiloye EA,* Odonkor GN,* Barner JC, Brown CM, Bamgbade BA, Aiyeolemi AA.* Factors influencing willingness to utilize the emergency department when experiencing sickle cell disease pain crises. Journal of the National Medical Association. 2025:117(5); 323–334.  

Presentations

• Ibiloye E,* Odonkor G,* Barner JC, Brown CM, Kang HK, Bamgbade BA. “Factors influencing willingness to utilize the emergency department among individuals living with sickle cell disease” at the International Society for Pharmacoeconomics and Outcomes Research 2024. Atlanta, GA. May 5-8, 2024
• Kang HA, Wang B, Barner JC, Ataga KI, and Mignacca RC, “Unintended consequences of the CDC’s 2016 opioid guideline on individuals with sickle cell disease,” at the American Association of Colleges of Pharmacy 2023 Annual Meeting, Aurora, CO, July 22-25, 2023.
• Ibiloye E,* Odonkor G,* Barner JC, Brown CM, Kang HK, Bamgbade BA,*  “Beliefs regarding patient experience in the emergency department among individuals living with sickle cell disease” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Boston, MA, May 7-10, 2023.

Healthcare Utilization and Costs among Texas Medicaid Patients with Sickle Cell Disease

Publications

• Odonkor GN,* Kang HA, Barner JC, Lawson KA, Fasipe T. Medical complications among children and adolescents with sickle cell disease in Texas Medicaid. Healthcare 2025, 13:18; 2288.
• Kang HA, Wang B,* Barner JC, Ataga KI, Mignacca RC, Chang A, Zhang Y. Opioid prescribing and outcomes in patients with sickle cell disease post-2016 CDC guideline. JAMA Internal Medicine. 2024;184(5):510-518.
• Kang HA, Barner JC, Rascati KL, Lawson KA, Mignacca RC. Impact of adherence to hydroxyurea on health outcomes among patients with sickle cell disease. American Journal of Hematology. 2023 Jan;98(1):90-101.
• Shukla N,* Barner JC, Lawson K, Rascati KL. Age-related healthcare services utilization for the management of sickle cell disease among Texas Medicaid patients. Journal of Pharmaceutical Health Services Research. 2021;12:523-530.
• Shukla N,* Barner JC, Rascati KL, Lawson K. Age-related prescription medication utilization for the management of sickle cell disease among Texas Medicaid patients. Journal of Opioid Management. 2021;174(4):301-310.

Presentations

• Okoye B,* Barner JC, Kang HA, Richards K. Association between comorbid depression and antidepressant adherence with adherence to disease-modifying therapies in patients with sickle cell disease in Texas Medicaid, at the American Society of Hematology Annual Meeting, Orlando, FL.  December 6-9, 2025.
• Okoye B,* Aiyeolemi A,* Odonkor G,* Bhalla A,* Barner JC, Catanzano S. “Prevalence of mental health conditions among individuals with sickle cell disease in Texas Medicaid” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Montreal, QC, Canada, May 13-16, 2025.
• Odonkor G,* Barner JC, Kang HA, Fasipe T. “Examination of age-related medical complications among pediatric, adolescent, and young adult patients with sickle cell disease in Texas Medicaid” at the International Society for Pharmacoeconomics and Outcomes Research 2024. Atlanta, GA. May 5-8, 2024. (Best Student Podium Award and Top 5% Finalist)
• Kang HA, Wang B, Barner JC, Ataga KI, and Mignacca RC, “Unintended Consequences of the CDC’s 2016 Opioid Guideline on Individuals with Sickle Cell Disease,” at the American Association of Colleges of Pharmacy 2023 Annual Meeting, Aurora, CO, July 22-25, 2023.
• Shukla N,* Barner JC, Rascati KL, Lawson K, “Prescription medication utilization for the management of sickle cell disease by age group” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting (virtual), May 16-20, 2020.
• Shukla N,* Barner JC, Rascati KL, Lawson K, “Age-related healthcare service utilization in sickle cell disease management” at Academy of Managed Care Pharmacy Annual Meeting (virtual), April 21-24, 2020.
• Kang HA,* Barner JC, Rascati KL, Lawson KA, Mignacca RC, “Association between hydroxyurea medication adherence and all-cause and disease-related healthcare expenditures among Texas Medicaid enrollees with sickle cell disease” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, New Orleans, LA, May 18-22, 2019.
• Barner JC, Kang HA,* Richards K, Bhor M, Paulose J, Kutlar A, “Association between vaso-occlusive crises and opioid use among Texas Medicaid recipients with sickle cell disease” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, New Orleans, LA, May 18-22, 2019.
• Barner JC, Kang HA,* Richards K, Bhor M, Paulose J, Kutlar A, “Association between hydroxyurea adherence and persistence and vaso-occlusive crises among Texas Medicaid recipients with sickle cell disease” at Academy of Managed Care Pharmacy Annual Meeting, San Diego, CA, March 26-28, 2019.
• Kang HA,* Barner JC, “Hydroxyurea medication adherence and opioid use among Texas Medicaid enrollees with sickle cell disease” at the American Pharmacists Association Annual Meeting, Seattle, WA, March 22-25, 2019.
• Kang HA,* Barner JC, Rascati KL, Lawson KA, Mignacca RC “Association between hydroxyurea medication adherence and vaso-occlusive crisis events among Texas Medicaid enrollees with sickle cell disease” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Baltimore, MD, May 19-23, 2018.
• Shukla N,* Barner JC, “Temporal use of medications for the management/treatment of sickle cell disease” at the Academy of Managed Care Pharmacy Annual Meeting, Boston, MA, April 23-26, 2018. 

MATERNAL HEALTH-RELATED RESEARCH

Publications

• Mueller H,* Barner JC, Brown CM, Stewart M. Exploring ambulatory care pharmacists’ beliefs and confidence in managing diabetes in perinatal women: A qualitative study guided by the theory of planned behavior. Forthcoming American Journal of Health Systems Pharmacists.
• Mueller J,* Pennington E,* Carr, A,* Barner JC. Effectiveness of telehealth for disease management during the perinatal period: a scoping review. Telemedicine and e-Health. 2025; 31(8).
• Pennington E,* Barner JC, Brown CM, Moczygemba LR, Patel DA. Predisposing, enabling, and need factors associated with postpartum depression treatment among women enrolled in Texas Medicaid. Maternal and Child Health. 2025 (July 17).
• Pennington E,* Barner JC, Brown CM, Moczygemba LR, Patel DA, Varisco TJ. Antidepressant adherence using group-based trajectory modeling among postpartum women with Texas Medicaid. Journal of Managed Care and Specialty Pharmacy. 2025;31(2):167-78.
• Pennington E,* Barner JC, Brown CM, Lawson KA. Pregnancy-related risk factors and receipt of postpartum care among Texas Medicaid pregnant enrollees: Opportunities for pharmacist services. Journal of the American Pharmacists Association. 2024;64(1):260-267.
• Lim H,* Barner JC. Impact of a workshop on student pharmacist confidence and comfort in counseling patients at risk for maternal mortality. Currents in Pharmacy Teaching and Learning. 2022;14(1):71-82.

Presentations

• Mueller J,* Carr A,* Pennington E,* Barner JC. “Telehealth for disease management: a scoping review of effectiveness in the perinatal period” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Montreal, QC, Canada, May 13-16, 2025.
• Mueller J, Barner JC, Brown CM, Stewart M. “Exploring ambulatory care pharmacists’ beliefs and confidence in managing diabetes in perinatal women” at the American Pharmacists Association Annual Meeting, Nashville, TN.  March 21-24, 2025.
• Pennington EL,* Barner JC, Brown CM, Moczygemba L, Patel D. “Predisposing, enabling, and need factors associated with postpartum depression treatment among women enrolled in Texas Medicaid” at the International Society for Pharmacoeconomics and Outcomes Research 2024. Atlanta, GA. May 5-8, 2024.
• Pennington EL,* Barner JC, Brown CM, Moczygemba L, Patel D. “Antidepressant adherence using group-based trajectory modeling among postpartum women with Texas Medicaid” at the International Society for Pharmacoeconomics and Outcomes Research 2024. Atlanta, GA. May 5-8, 2024.